7 FTSE 100 stocks to consider for 2022

The FTSE 100 is just about hanging on to a double-digit gain for 2021.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Businessman touching on number 2022 for preparation

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

‘Tis the season for reflecting on the past year and looking ahead to the coming one.
 
Over in the US, the S&P 500 index is up over 25%, as I’m writing. It’s printed multiple record highs through 2021 led by heavyweight tech stocks. Apple has recently been flirting with becoming the world’s first three-trillion-dollar company. Talk about the goose is getting fat!
 
Here in the UK, the performance of the FTSE 100 hasn’t been quite as spectacular. But our blue-chip index is just about hanging on to a double-digit gain at the moment. Mind, it remains some way below its pre-pandemic levels.
 
And like Jacob Marley, Mr Footsie goes into the new year bearing a weighty chain. One forged by the recent appearance of the Omicron virus variant, surging inflation, and last week’s decision by the Bank of England to hike interest rates to 0.25%.
 
Let’s have a look at the outlook for some of the UK’s popular blue-chip stocks. 

Shell and BP

The FTSE 100 oil giants have made strong gains this year — Shell (+31%) and BP (+37%) — although the shares of both (and the oil price) are currently off their highs. There are some fears the surge in Covid cases could slow, if not derail, the oil-price recovery seen in 2021.
 
Still, the recent weakness in Shell and BP’s shares has pushed their forecast 2022 dividend yields up to 4.6% and 5.1% respectively. They look like attractive income stocks to my eye, and have potential for capital gains if the oil-price recovery resumes next year.

Rolls-Royce

The resurgence of Covid has loomed even larger over the recent performance of the shares of airlines and engine-maker Rolls-Royce. At one point, the latter’s shares were up 33% since the start of the year. They’re now up just 3%.
 
On the positive side, while there’ll be no dividend for the foreseeable future, a free cash flow (FCF) target of at least £750m — possibly in 2022 but probably 2023 — gives an attractive FCF yield of over 8%. The company has a good bit of work to do if it’s to reach this target, but it’s a credible long-term recovery stock, in my view.

AstraZeneca and GlaxoSmithKline

Like the oil giants, the Footsie’s big pharma groups AstraZeneca (+19%) and GlaxoSmithKline (+26%) have performed well in 2021. They don’t sport as generous forward yields as their oil counterparts — 2.6% and 3.4% respectively — but their businesses are less sensitive to the macro-economic environment.
 
AstraZeneca completed its $39bn takeover of Alexion Pharmaceuticals in the third quarter of 2021. It’s not unknown for such mega-deals to give the acquirer a bout of indigestion, and I’ll be watching how the integration progresses in the coming months.
 
GlaxoSmithKline is heading the opposite way in 2022, planning to break itself up with a demerger of its consumer healthcare business. Former Tesco boss Dave Lewis has just been appointed chair designate for this business and it looks a good move to me. I’ve long felt a break-up of GSK would unlock value for shareholders and continue to do so. 

BT

Takeover speculation has surrounded BT through 2021 and it’s shares are up 27% since the start of the year. A recent rumour of interest from India’s Reliance Industries and news that billionaire Patrick Drahi has increased his stake in BT from 12% to 18% have provided the latest fuel for speculation.
 
The company reinstated its dividend at the half-year stage and the forward yield is a very decent 4.6%. Dividends, debt obligations and investment for growth will be something of a balancing act. But, like Rolls-Royce, I see BT as a credible long-term recovery stock. A value-unlocking bid for the company — or part of it — can’t be ruled out either. 

Lloyds

Lloyds has been another market outperformer in 2021. Its shares are up 30% at the moment. They responded positively to the recent Bank of England interest-rate hike, as higher rates generally make for higher profits on banks’ lending activities.
 
However, if rate increases were to cut off economic growth in 2022, lower income and higher debts could cast a pall over Lloyds’ performance. On balance though, I see a forecast dividend yield of 5.5% as sufficient to make the stock an attractive one for me to consider as an income-seeker.
 
As I’m all set to ensconce myself in a comfy chair by the fire, it only remains for me to wish one and all a happy, healthy and prosperous 2022. Keep it Foolish!

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester doesn't own any shares mentioned in this article. The Motley Fool UK has recommended Apple, GlaxoSmithKline, Lloyds Banking Group, and Tesco.

More on Investing Articles

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

6.9% dividend yield! 2 cheap stocks to consider for a £1,380 passive income

Looking for a market-beating passive income? These FTSE 100 and FTSE 250 dividend stocks could provide a healthy second income…

Read more »

Mature black couple enjoying shopping together in UK high street
Investing Articles

Potentially 34% undervalued, should I be watching the boohoo share price?

The boohoo share price has seen a rocky few years, but with signs that the economy is improving, could this…

Read more »

Investing Articles

Is the Amazon share price primed for a drop?

The Amazon share price has been on a tear for the last year, but can this trend continue? Gordon Best…

Read more »

Photo of a man going through financial problems
Investing Articles

Down 15% in a week! What’s gone wrong with the National Grid share price?

The National Grid share price isn't supposed to crash but now it has. Harvey Jones is wondering whether to take…

Read more »

Group of young friends toasting each other with beers in a pub
Investing Articles

Taylor Wimpey just paid me £158.78. I’m aiming to turn that into a £100k yearly second income

Harvey Jones says small, regular dividend payments can turn a few pounds into a mighty second income, if he gives…

Read more »

A pastel colored growing graph with rising rocket.
Value Shares

These FTSE 250 shares are tipped to rise 14% to 18% in the next year!

Looking for the best FTSE 250 momentum shares to buy? Here are two that City analysts expect to soar in…

Read more »

Young mixed-race woman jumping for joy in a park with confetti falling around her
Investing Articles

Lloyds’ share price is up 20% in 3 months! How high can it go?

Lloyds’ share price has ripped higher recently. Here, Edward Sheldon provides his view on the level it could potentially climb…

Read more »

Investing Articles

Why the Rolls-Royce share price could continue to outperform

The Rolls-Royce share price keeps moving forward, but this Fool thinks it's still behind where it ought to be after…

Read more »